NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies
4.7 (561) · $ 8.99 · In stock
An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.
PDF) Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to
Frontiers Vaccine-associated enhanced disease in humans and
PDF) Reduced immunogenicity of a live Salmonella enterica serovar
The Role of Vaccines in Combating Antimicrobial Resistance
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant
Controlled Human Infection Models To Accelerate Vaccine
Vaccines, Free Full-Text
Intestinal helminth infection impairs oral and parenteral vaccine
Vaccines platforms and COVID-19: what you need to know
Bioengineering, Free Full-Text